» Articles » PMID: 8921171

An Acid Phosphatase Assay for Quantifying the Growth of Adherent and Nonadherent Cells

Overview
Journal Anal Biochem
Publisher Elsevier
Specialty Biochemistry
Date 1996 Oct 1
PMID 8921171
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

We describe an acid phosphatase assay for determination of cell growth based on quantification of cytosolic acid phosphatase activity. The assay is based on the hydrolysis of the p-nitrophenyl phosphate by intracellular acid phosphatases in viable cells to produce p-nitrophenol. For all cell types examined, absorbance of p-nitrophenol at 405 nm is directly proportional to the cell number in the range of 10(3)-10(5) cells. The assay can quantify as few as 1000 cells per well in 96-well microtiter plates. The acid phosphatase assay was used to count various adherent and nonadherent cells, including human tumors, L6, and HT-2 cells. We also demonstrate the utility of this assay for analysis of growth factor and cytokine bioactivity on mammalian cells in culture. In comparison to [3H]thymidine incorporation, the acid phosphatase assay has similar sensitivity but a wider linear response range. The method also shows higher sensitivity and reproducibility in comparison to cell proliferation assays based on the reduction of tetrazolium salts. Because of the ease of use, sensitivity, and low cost, the acid phosphatase method is especially suited to applications where a large number of samples are assayed.

Citing Articles

ARHGAP25: a novel player in the Pathomechanism of allergic contact hypersensitivity.

Czaran D, Sasvari P, Lorincz K, Ella K, Gellen V, Csepanyi-Komi R Front Immunol. 2025; 16:1509713.

PMID: 40078992 PMC: 11896868. DOI: 10.3389/fimmu.2025.1509713.


The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre-clinical study.

Low K, Foulkes P, Hills F, Roberts H, Stordal B Cancer Med. 2024; 13(18):e70248.

PMID: 39315544 PMC: 11420655. DOI: 10.1002/cam4.70248.


Functional assays reflective of cancer hallmarks in BT-549 cells are not impacted by media supplemented with exercise-trained plasma.

Darragh I, Martinez-Pacheco S, ODriscoll L, Egan B Exp Physiol. 2023; 109(7):1124-1133.

PMID: 37991325 PMC: 11215463. DOI: 10.1113/EP091383.


Comparative Evaluation of the Cytotoxicity of Doxorubicin in BT-20 Triple-Negative Breast Carcinoma Monolayer and Spheroid Cultures.

Ncube K, Jurgens T, Steenkamp V, Cromarty A, van den Bout I, Cordier W Biomedicines. 2023; 11(5).

PMID: 37239157 PMC: 10216410. DOI: 10.3390/biomedicines11051484.


In Vitro Analysis of Cytotoxic Activities of Targeting / Genes in Breast Cancer Cells.

Sher A, Tabassum S, Wallace H, Khan A, Karim A, Gul S Plants (Basel). 2023; 12(5).

PMID: 36904007 PMC: 10005423. DOI: 10.3390/plants12051147.